RxDoctor Payments Data

Swati Elchuri

Pediatric Endocrinology · Ventura, CANPI 1750569133

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $171,392 of the $210,325 with a category attached, or 81.5%. Sanofi-aventis U.S. LLC accounts for 92.4% of it on its own, with 20 other manufacturers making up the rest. Among pediatric endocrinology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$210,325in general payments, 2019–2025

Across 288 payments — averaging $730.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$194K
  • Sanofi$7K
  • Insulet Corporation$7K
  • Medtronic$563
  • Dexcom, Inc.$419
  • Ascendis Pharma Endocrinology Inc$348
  • plus $1K from 15 others

What the payments were for

  • Speaking & faculty fees$171,39281%
  • Travel & lodging$31,26615%
  • Food & beverage$7,6674%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$210,325 in reported general payments places this provider in the 95th percentile of 168 pediatric endocrinology providers in California.

See all pediatric endocrinology providers in California

Other pediatric endocrinology in Ventura

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →